Olympic 800-meter finalist Peter Bol on Tuesday said his provisional doping suspension has been lifted after the A and B samples didn't match.
Usually testing of the B sample confirms the original adverse finding in doping cases.
I was just informed that my B sample did not match my A sample, Bol posted on Twitter.
My provisional suspension has been lifted by Sport Integrity Australia.
Sport Integrity Australia later confirmed testing of the B sample by a World Anti-Doping Agency-accredited laboratory showed an atypical finding, but that in itself is not the same as a negative test result.
The investigation into the matter remains ongoing. Sport Integrity Australia will, as part of its investigation, proceed to consider whether any anti-doping rule violations have been committed, the government-backed agency said in a statement.
It is not possible to provide a timeframe at this point.
Bol repeated Tuesday that he's never taken banned performance-enhancing substances and he described the last month as a nightmare.
Athletics Australia announced last month that Bol had failed an out-of-competition test on Oct. 11. The 28-year-old runner's A sample tested positive to the banned drug erythropoietin, known as EPO.
The relief I am feeling is hard to describe. Bol said after the B sample results returned.
The last month has been nothing less than a nightmare. I wish that the results of my A sample had not been leaked, but there is nothing I can do about that.
To say it one more time: I am innocent and have not taken this substance as I was accused."
Bol placed fourth in the 800-meter final at the Tokyo Olympics and was a silver medalist at the 2022 Commonwealth Games.
Richard Ings, the former head of Australia's anti-doping agency, described the differing results from A and B samples as exceedingly rare.
Questions need asking of the lab and how it processed and assessed the A sample," Ings posted on Twitter.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app